Harry Solis

Harry Solis is a Business Development Director at Labcorp Early Development, where they focus on safety assessment and early phase development solutions in drug development. With over 10 years of experience in business development within the pharma and biotech sectors, and more than 15 years in sales, product marketing, and corporate training, Harry has specialized in oncology and has worked with a diverse range of clients including academic institutions and government accounts. They have held various positions, including Business Development Manager at Biognosys AG and Senior Product Manager at Millennium Pharmaceuticals, and have a background in oncology sales training with MedImmune. Harry is currently pursuing a B.S. in Management and a B.S. in Petroleum Land Management at Louisiana State University.